Sabra Healthcare REIT (NASDAQ:SBRA) Rating Lowered to "Sell" at Wall Street Zen

Key Points

• Wall Street Zen downgraded Sabra Healthcare REIT (NASDAQ: SBRA) from “hold” to “sell,” adding a negative note to the stock’s recent analyst coverage.
• Other analysts remain mixed: Wells Fargo and several others have raised price targets, while the overall consensus still stands at “Moderate Buy” with a $22.00 price target.
• Sabra reported quarterly EPS of $0.16, matching expectations, while revenue came in at $221.75 million, above estimates and up 20.9% year over year.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued to clients and investors on Sunday.

SBRA has been the topic of several other reports. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an "overweight" rating in a report on Thursday, March 26th. Cantor Fitzgerald upped their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a "neutral" rating in a report on Tuesday, February 17th. UBS Group increased their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a "neutral" rating in a research report on Thursday, February 19th. Scotiabank lifted their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "sector perform" rating in a research note on Monday, March 2nd. Finally, Weiss Ratings downgraded shares of Sabra Healthcare REIT from a "buy (a-)" rating to a "buy (b+)" rating in a research report on Friday, May 1st. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, Sabra Healthcare REIT has a consensus rating of "Moderate Buy" and a consensus price target of $22.00.

Sabra Healthcare REIT Stock Performance

SBRA opened at $20.75 on Friday. The firm has a market cap of $5.23 billion, a P/E ratio of 32.94, a price-to-earnings-growth ratio of 1.66 and a beta of 0.67. Sabra Healthcare REIT has a 52-week low of $17.08 and a 52-week high of $21.07. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. The business's fifty day moving average is $20.24 and its 200-day moving average is $19.41.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts' consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company had revenue of $221.75 million for the quarter, compared to analysts' expectations of $209.20 million. During the same quarter last year, the business earned $0.37 earnings per share. Sabra Healthcare REIT's revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts expect that Sabra Healthcare REIT will post 1.5 EPS for the current fiscal year.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of hedge funds have recently made changes to their positions in SBRA. Rothschild Investment LLC increased its position in Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 889 shares in the last quarter. Smartleaf Asset Management LLC boosted its position in Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 714 shares in the last quarter. Founders Capital Management acquired a new stake in Sabra Healthcare REIT in the third quarter valued at approximately $28,000. Strengthening Families & Communities LLC bought a new stake in shares of Sabra Healthcare REIT during the fourth quarter worth $29,000. Finally, Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT during the third quarter worth $30,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.